Chuck Silberstein
Chief Financial Officer @ GentiBio
About Chuck Silberstein
Chuck Silberstein serves as the Chief Financial Officer, holding both an MD and an MBA.
Known information
Chuck Silberstein holds the position of Chief Financial Officer, bringing a unique blend of medical and business expertise to his role. He is distinguished by his educational background, having earned both a Doctor of Medicine (MD) and a Master of Business Administration (MBA). His dual qualifications enable him to effectively bridge the gap between clinical concerns and financial strategies in his organization.
About GentiBio
GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.